Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: A EULAR extension of STROBE guidelines based on experience from biologics registries

Abstract

The EULAR Study Group on Longitudinal Observational Registers and Drug Studies presents the launch of a checklist to help authors in writing reports of longitudinal observational drug studies in rheumatology, editors and peer reviewers in reviewing manuscripts for publication, and readers in critically appraising published articles.

Keywords

• checklist
• longitudinal observational drug study
• register
• rheumatology